Part I: Basic Science of Lung Cancer -- Genomic Alterations in Lung Cancer -- Epigenetic Events in Lung Cancer -- Part II: Clinical Investigations -- Interventional Pulmonology -- Pathology of Lung Cancer -- Role of Radiologic Imaging in Lung Cancer -- Place and Role of PET/CT in the Diagnosis and Staging of Lung Cancer -- Surgical Staging of Lung Cancer -- Part III: Basic Treatment Considerations -- Surgery in Lung Cancer -- Radiobiology of the Normal Lung Tissue and Lung Tumors -- Radiotherapy of Lung Cancer: Impact of Time, Dose, and Fractionation -- Medical Physics of Radiation Therapy of Lung Cancer -- Tumor Motion Control -- PET and PET/CT in Treatment Planning -- The Radiation Target in Non-Small Cell Lung Cancer -- The Radiation Target in Small-Cell Lung Cancer -- Radiation Sensitizers -- Radioprotectors and Chemoprotectors in the Management of Lung Cancer -- Classic Chemotherapy for Lung Cancer -- Targeted Therapy for Lung Cancer -- Immunotherapy for Lung Cancer -- Combined Radiotherapy and Chemotherapy: Theoretical Considerations and Biological Premises -- Mechanisms of Action of Radiotherapy and Immunotherapy in Lung Cancer: Implications for Clinical Practice -- Part IV: Current Treatment Strategies in Early-Stage Non-Small Cell Lung Cancer -- Early Non-small Cell Lung Cancer: The Place of Radical Non-SABR Radiation Therapy -- Never-Ending Story: Surgery Versus SBRT in Early-Stage NSCLC -- Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer -- Role of Postoperative Radiation Therapy in Non-Small Cell Lung Cancer -- Photodynamic Therapy (PDT) as Treatment Option in Lung Cancer -- The Role of Thermal Ablation in the Treatment of Stage I Non-Small Cell Lung Cancer -- Part V: Current Treatment Strategies in Locally Advanced and Metastatic Non-Small Cell Lung Cancer -- Lung Dose Escalation -- Multimodality Treatment of Stage IIIA/N2 NSCLC - Why Always NO to Surgery -- Multimodality Treatment of Stage IIIA/N2 NSCLC: When YES to Surgery -- Combined Radiation Therapy and Chemotherapyas an Exclusive Treatment Option in Locally Advanced Inoperable Nonsmall Cell Lung Cancer -- Do New Drugs Offer Hope for Maintenance/Consolidation Therapy Given After Concurrent Radiochemotherapy? -- Prophylactic Cranial Irradiation in Locally Advanced Nonsmall Cell Lung Cancer -- Palliative Thoracic Radiotherapy of Non-Small Cell Lung Cancer -- Intraoperative Radiotherapy in Lung Cancer -- Brachytherapy for Lung Cancer -- Oligometastatic Disease - Basic Aspects and Clinical Results -- Part VI: Current Treatment Strategies in Small Cell Lung Cancer -- Radiation Therapy in Limited Disease Small Cell Lung Cancer -- Role of Thoracic Radiation Therapy in Extensive Disease Small Cell Lung Cancer -- Prophylactic Cranial Irradiation in Small Cell Lung Cancer -- Part VII: Treatment in Specific Patient Groups and Other Settings -- Role of Radiation Therapy for Lung Cancer in Elderly -- Lung Cancer Recurrence Treated with Radiation Therapy -- Treatment of Second Lung Cancers -- Radiation Therapy for Metastatic Lung Cancer - Brain Metastasis -- Radiation Therapy for Metastatic Lung Cancer - Bone Metastasis and Metastatic Spinal Cord Compression -- Radiation Therapy for Metastatic Lung Cancer - Liver Metastasis -- Advances in Supportive and Palliative Care for Lung Cancer Patients -- Part VIII: Other Intrathoracic Malignancies -- Thymic Cancer -- Mesothelioma -- Tracheal Tumors -- Pulmonary Carcinoid -- Part IX: Treatment-Related Toxicity -- Hematological Toxicity in Lung Cancer -- Radiation Therapy-Induced Lung and Heart Toxicity -- Spinal Cord Toxicity -- Radiation Induced Esophageal Toxicity -- Brain Toxicity -- Part X: Quality of Life Studies and Prognostic Factors -- Quality of Life Outcomes in Radiotherapy of Lung Cancer -- Importance of Prognostic Factors in Lung Cancer -- Part XI: Technological Advances in Lung Cancer -- Intensity-Modulated Radiation Therapy and Volumetric-Modulated Arc Therapy for Lung Cancer -- Image-Guided Radiotherapy in Lung Cancer with Kilovoltage and Megavoltage Treatment Planning and Delivery -- Heavy Particles in Nonsmall Cell Lung Cancer -- Heavy Particles in Nonsmall Cell Lung Cancer: Carbon Ions -- The Role of Nanotechnology for Diagnostic and Therapy Strategies in Lung Cancer -- Part XII: Clinical Research in Lung Cancer -- Translational Research in Lung Cancer -- Radiation Oncology of Lung Cancer: Why We Fail(ed) in Clinical Research? -- Randomized Clinical Trials: Pitfalls in Design, Analysis, Presentation, and Interpretation.